CBIO
Crescent Biopharma
CBIO
CBIO
31 hedge funds and large institutions have $109M invested in Crescent Biopharma in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
4% less capital invested
Capital invested by funds: $114M → $109M (-$4.93M)
Holders
31
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$236K | |
| 2 | +$210K | |
| 3 | +$178K | |
| 4 |
Renaissance Technologies
New York
|
+$135K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$100K |
Top Sellers
| 1 | -$628K | |
| 2 | -$122K | |
| 3 | -$49.1K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$15.8K |
| 5 |
Citigroup
New York
|
-$12K |